MetaCap

Context Therapeutics Earnings

NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.3042+0.0052 (+1.74%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Fiscal period

Sep/2026

EPS estimate

$-0.09

Context Therapeutics earnings summary

Context Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.09.

Summary generated from market data by MetaCap's automated system. Methodology

Related